Prof. Dr. UĞUR COŞKUN

1. Incidence and Patterns of Second Primary Malignancies in Genitourinary Cancer Survivors: A 20-Year Single-Center Experience

Eroglu I., Avsar H., sutcuoglu o., tahtaci g., Gürler F., Coskun U., et al.

Journal of oncological sciences , cilt.12, sa.1, ss.41-50, 2026 (Scopus, TRDizin)

2. Receptor Status Differences in Prognosis for Breast Cancer

DELİGÖZ BİLDACI Y., Yamac D., COŞKUN U.

GAZI MEDICAL JOURNAL , cilt.35, sa.3, ss.224-227, 2024 (ESCI, Scopus) Sürdürülebilir Kalkınma

3. Nivolumab-induced sensory ganglionopathy.

Coskun Ö., Sahin H., Yalcin S., Sahin Y. C., Coskun U.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , cilt.29, sa.6, ss.1510-1515, 2023 (SCI-Expanded, Scopus)

4. Lobular breast cancer metastasis to uterus during adjuvant tamoxifen treatment: A case report and review of the literature.

Aytekin A., Bilgetekin I., Ciltas A., Ogut B., Coskun U., Benekli M.

Journal of cancer research and therapeutics , cilt.14, sa.5, ss.1135-1137, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer

Cinieri S., Chan A., Altundag K., Vandebroek A., Tubiana-Mathieu N., Barnadas A., et al.

CLINICAL BREAST CANCER , cilt.17, sa.2, ss.91-99, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Renal cell cancer: overview of the current therapeutic landscape

ERMAN M., Benekli M., Basaran M., Bavbek S., Buyukberber S., Coskun U., et al.

EXPERT REVIEW OF ANTICANCER THERAPY , cilt.16, sa.9, ss.955-968, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients

GÜMÜŞAY Ö., Cetin B., Benekli M., Gurcan G., İLHAN M. N., Bostankolu B., et al.

JOURNAL OF CANCER EDUCATION , cilt.31, sa.2, ss.308-313, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Crizotinib-induced toxicity in an experimental rat model

Gümüşay Ö., Esendagli-Yilmaz G., Üner A., Çetin B., Buyukberber S., Benekli M., et al.

WIENER KLINISCHE WOCHENSCHRIFT , cilt.128, ss.435-441, 2016 (SCI-Expanded, Scopus)

9. Comparison of Long-Term Outcomes in Real-World Patients between Resolute Zotarilumus-Eluting and Paclitaxel-Eluting Stents in Small Vessel

Kilickesmez K. O., Kocas B., Yildiz A., Coskun U., ERSANLI M. K., Arat A., et al.

Angiology , cilt.67, sa.5, ss.490-495, 2016 (SCI-Expanded, Scopus)

10. Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab

Tonyali O., Coskun U., Yuksel S., İNANÇ M., Bal O., Akman T., et al.

BREAST , cilt.25, ss.22-26, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients

Algin E., ÖZET A., GÜMÜŞAY Ö., Yilmaz G., Buyukberber S., Coskun U., et al.

WIENER KLINISCHE WOCHENSCHRIFT , cilt.128, ss.42-47, 2016 (SCI-Expanded, Scopus)

12. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors

Cetin B., Gonu I. I., Buyukberber S., Afsar B., Gumusay O., Algm E., et al.

TUMOR BIOLOGY , cilt.36, sa.11, ss.8471-8478, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

Baykara M., Benekli M., EKİNCİ Ö., Irkkan S. C., Karaca H., Demirci U., et al.

JOURNAL OF GASTROINTESTINAL SURGERY , cilt.19, sa.9, ss.1565-1571, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)

İÇLİ F., Altundag K., AKBULUT H., PAYDAŞ S., BAŞARAN G., Saip P., et al.

BREAST CANCER , cilt.22, sa.5, ss.480-485, 2015 (SCI-Expanded, Scopus)

15. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

TURAN N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.

CHINESE JOURNAL OF CANCER RESEARCH , cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded, Scopus)

16. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study

Abali H., ÇELİK İ., Karaca B., TURNA Z. H., Saglam E. K., Akman T., et al.

JOURNAL OF BUON , cilt.20, sa.4, ss.1137-1141, 2015 (SCI-Expanded, Scopus)

17. Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites

Gumusay O., Benekli M., EKİNCİ Ö., Baykara M., ÖZET A., Coskun U., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.45, sa.5, ss.416-421, 2015 (SCI-Expanded, Scopus)

18. Factors predicting the development of distant metastases in patients with head and neck squamous cell carcinoma: A retrospective study from a single centre

Gumusay O., ÖZET A., Buyukberber S., Baykara M., Coskun U., Cetin B., et al.

JOURNAL OF BUON , cilt.20, sa.2, ss.521-526, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Functional and Morphological Effects of Systemic Bevacizumab on Cancer Patients' Eyes

Yildiz B. K., ÖZDEK Ş., Demirci U., Ceylanoglu K. S., Ozmen M. C., Baykara M., et al.

OPTOMETRY AND VISION SCIENCE , cilt.92, sa.1, ss.102-106, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin

Algin E., ÖZET A., Gumusay O., Cetin B., AKDEMİR Ü. Ö., Benekli M., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.28, sa.9, ss.891-896, 2014 (SCI-Expanded, Scopus)

21. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Kaplan M. A., Isikdogan A., Koca D., KÜÇÜKÖNER M., Gumusay O., Yildiz R., et al.

BREAST CANCER , cilt.21, sa.6, ss.677-683, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Management of brain metastases from non-small cell lung cancer

Baykara M., KURT G., Buyukberber S., Demirci U., Ceviker N., Algin E., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.10, sa.4, ss.915-921, 2014 (SCI-Expanded)

23. Outcome of 561 non-metastatic triple negative breast cancer patients: Multi-center experience from Turkey

Budakoglu B., Altundag K., Aksoy S., Kaplan M. A., Ozdemir N. Y., Berk V., et al.

JOURNAL OF BUON , cilt.19, sa.4, ss.872-878, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)

Cetin B., Benekli M., Turker I., Koral L., Ulas A., Dane F., et al.

JOURNAL OF CHEMOTHERAPY , cilt.26, sa.5, ss.300-305, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Factors predicting recurrence in patients with grade III glial tumors: Impact of adjuvant temozolomide on recurrence

Gumusay O., Cetin B., Ozet A., Demirci U., Buyukberber S., Coskun U., et al.

JOURNAL OF BUON , cilt.19, sa.4, ss.1035-1040, 2014 (SCI-Expanded, Scopus)

26. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer

Turan N., Benekli M., Dane F., Unal O. U., Kara H. V., Koca D., et al.

THORACIC CANCER , cilt.5, sa.5, ss.398-404, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma

Cetin B., Afsar B., Deger S. M., IŞIK GÖNÜL İ., Gumusay O., ÖZET A., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.46, sa.6, ss.1081-1087, 2014 (SCI-Expanded, Scopus)

28. Clear Cell Adenocarcinoma of the Uterine Cervix: A Case Report and Review of the Literature

Baykara M., Benekli M., ERDEM O. A., Taskiran C., Demirci U., Vargol E., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.36, sa.2, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

Gumusay O., Coskun U., Akman T., Ekinci A. S., Kocar M., Erceleb O. B., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.140, sa.1, ss.151-157, 2014 (SCI-Expanded, Scopus)

30. Docetaxel and Cisplatin in First Line Treatment of Patients with Unknown Primary Cancer: A Multicenter Study of the Anatolian Society of Medical Oncology

Demirci U., Coskun U., Karaca H., Dane F., Ozdemir N. Y., Ulas A., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.4, ss.1581-1584, 2014 (SCI-Expanded, Scopus)

31. Clinical and prognostic importance of XIAP and USP8 in advanced stages of non-small cell lung cancer.

Baykara M., Yaman M., Buyukberber S., Tufan G., Demirci U., Benekli M., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.18, sa.4, ss.921-7, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

Tonyali O., Coskun U., Sener N., İNANÇ M., Akman T., Ulas A., et al.

ONKOLOGIE , cilt.36, sa.10, ss.554-558, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience

KEFELİ U., Benekli M., Sevinc A., Yildiz R., Kaplan M. A., Ciltas A., et al.

ONCOLOGY LETTERS , cilt.6, sa.2, ss.605-611, 2013 (SCI-Expanded, Scopus)

34. The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N-0 head and neck cancers

Cetin B., Atasever T., AKDEMİR Ü. Ö., Senturk S., Tufan G., Turan N., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.270, sa.8, ss.2307-2313, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers

Baykara M., Buyukberber S., Ozturk B., Coskun U., Kaplan M. A., Unsal D. K., et al.

TUMORI , cilt.99, sa.4, ss.469-473, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Prognostic Factors in Gastrointestinal Stromal Tumors: Multicenter Experience of 333 Cases from Turkey

Seker M., Sevinc A., YILDIZ R., Cihan S., Kaplan M. A., Gokdurnali A., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.124, ss.768-775, 2013 (SCI-Expanded)

37. Efficacy of Sunitinib in Turkish Patients with Gastrointestinal Stromal Tumors; Retrospective Multicenter Experience

KEFELİ U., Buyukberber S., Akyol M., Yildiz R., Kaplan M. A., Ciltas A., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.124, ss.647-652, 2013 (SCI-Expanded, Scopus)

38. Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?

Cetin B., Berk V., Kaplan M. A., Afsar B., Tufan G., Ozkan M., et al.

CLINICAL GENITOURINARY CANCER , cilt.11, sa.2, ss.141-148, 2013 (SCI-Expanded, Scopus)

39. Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer

Tonyali O., Benekli M., Berk V., Coskun U., ÖZKAN M., Yildiz R., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.139, sa.6, ss.981-986, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

Demirci U., Tufan G., Aktas B., Balakan O., ALACACIOĞLU A., Dane F., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.139, sa.5, ss.829-835, 2013 (SCI-Expanded, Scopus)

41. Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study

Akinci M. B., Algin E., Inal A., Odabas H., Berk V., Coskun U., et al.

JOURNAL OF BUON , cilt.18, sa.2, ss.314-320, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology

Arpaci E., Yetisyigit T., Seker M., Uncu D., ÜYETÜRK Ü., Oksuzoglu B., et al.

MEDICAL ONCOLOGY , cilt.30, sa.1, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience

Cetin B., Benekli M., Dane F., Boruban C., Gumus M., Oksuzoglu B., et al.

BREAST CARE , cilt.8, sa.1, ss.67-70, 2013 (SCI-Expanded, Scopus)

44. Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

Cetin B., Kaplan M. A., Berk V., Tufan G., Benekli M., Isikdogan A., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.43, sa.1, ss.28-32, 2013 (SCI-Expanded, Scopus)

45. Efficacy and Safety of Concomitant Chemoradiotherapy with Cisplatin and Docetaxel in Patients with Locally Advanced Squamous Cell Head and Neck Cancers

Baykara M., Buyukberber S., Ozturk B., Coskun U., Unsal D. K., Demirci U., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.4, ss.2557-2561, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy.

Demirci U., Yaman M., Buyukberber S., Coskun U., Baykara M., Uslu K., et al.

International immunopharmacology , cilt.14, sa.4, ss.546-9, 2012 (SCI-Expanded, Scopus)

47. Hyperthyroidism and thyroid autoimmunity induced by sorafenib in metastatic renal cell cancer

Degertekin C. K., Coskun U., TÖRÜNER F. S., Akturk M. Y., Demirci U.

ENDOCRINE , cilt.42, sa.3, ss.756-757, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer

Tonyali O., Coskun U., Sener N., İNANÇ M., Akman T., Oksuzoglu B., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.138, sa.12, ss.2145-2151, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

Cetin B., Benekli M., Oksuzoglu B., Koral L., Ulas A., Dane F., et al.

ONKOLOGIE , cilt.35, sa.12, ss.740-745, 2012 (SCI-Expanded, Scopus)

50. Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer

YILDIZ R., Benekli M., ÖZKAN M., Alkis N., Berk V., Kaplan M. A., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.138, sa.11, ss.1845-1852, 2012 (SCI-Expanded)

51. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients

Kaya A. O., Gunel N., Benekli M., Akyurek N., Buyukberber S., Tatli H., et al.

JOURNAL OF BUON , cilt.17, sa.4, ss.663-668, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy

Kaya A. O., Coskun U., ÖZKAN M., Sevinc A., Yilmaz A. U., Gumus M., et al.

ONKOLOGIE , cilt.35, sa.10, ss.576-580, 2012 (SCI-Expanded, Scopus)

53. A previously unreported malignancy of the thyroid

Cetin B., Buyukberber S., Senturk S., Uluoglu O., Coskun U., Benekli M.

MEDICAL ONCOLOGY , cilt.29, sa.3, ss.1418-1420, 2012 (SCI-Expanded, Scopus)

54. The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens

Kaya A. O., Coskun U., Gumus M., Dane F., ÖZKAN M., Isikdogan A., et al.

JOURNAL OF CHEMOTHERAPY , cilt.24, sa.4, ss.217-220, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Trabectedin in advanced soft tissue sarcoma: case series

Demirci U., Buyukberber S., Yetisyigit T., Dizdar O., Benekli M., Alkis N., et al.

JOURNAL OF BUON , cilt.17, sa.3, ss.591-592, 2012 (SCI-Expanded, Scopus)

56. Synchronous Bilateral Breast Cancer in a Patient With Kindler Syndrome

Tonyali O., Tufan G., Benekli M., Coskun U., Buyukberber S.

CLINICAL BREAST CANCER , cilt.12, sa.2, ss.145-146, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Long term experience in high grade glial tumors with temozolomide

Demirci U., Buyukberber S., Coskun U., Akmansu M., Yaman E., Baykara M., et al.

JOURNAL OF BUON , sa.2, ss.357-362, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. Prognostic Factors for Overall Survival in Patients With Metastatic Colorectal Carcinoma Treated With Vascular Endothelial Growth Factor-Targeting Agents

Cetin B., Kaplan M. A., Berk V., Ozturk S. C., Benekli M., Isikdogan A., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.3, ss.1059-1063, 2012 (SCI-Expanded, Scopus)

59. Clinicopathological Features in Bilateral Breast Cancer

Baykara M., Ozturk S. C., Buyukberber S., Helvaci K., Ozdemir N., Alkis N., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.9, ss.4571-4575, 2012 (SCI-Expanded, Scopus)

60. Lymphoproliferative Disorders in Multiple Primary Cancers

Demirci U., Ozdemir N., Benekli M., Babacan N. A., Cetin B., Baykara M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.1, ss.383-386, 2012 (SCI-Expanded, Scopus)

61. Hepatotoxicity associated with lapatinib in an experimental rat model

Demirci U., Buyukberber S., Yilmaz G., KEREM M., Coskun U., ÜNER A., et al.

EUROPEAN JOURNAL OF CANCER , cilt.48, sa.2, ss.279-285, 2012 (SCI-Expanded, Scopus)

62. Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

Baykara M., Coskun U., Berk V., Ozkan M., Kaplan M. A., Benekli M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.10, ss.5119-5124, 2012 (SCI-Expanded, Scopus)

63. Efficacy and Toxicity of Gemcitabine Plus Docetaxel Combination as a Second Line Therapy for Patients with Advanced Stage Soft Tissue Sarcoma

Kaya A. O., Buyukberber S., ÖZKAN M., Alkis N., Sevinc A., Ozdemir N. Y., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.2, ss.463-467, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

64. Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience

Ozkan M., Berk V., Kaplan M. A., Benekli M., Coskun U., Bilici A., et al.

NEOPLASMA , cilt.59, sa.1, ss.38-42, 2012 (SCI-Expanded, Scopus)

65. Kaposi's sarcoma in patients with ulcerative colitis receiving immunosuppressive drugs: Report of a case

Cetin B., Buyukberber S., Yilmaz I. B., YILDIZ R., Coskun U., Benekli M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.22, sa.6, ss.621-625, 2011 (SCI-Expanded)

66. Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma

Baykara M., Akkus M., YILDIZ R., IŞIK GÖNÜL İ., DURSUN A., Coskun U., et al.

INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.11, sa.12, ss.2227-2231, 2011 (SCI-Expanded, Scopus)

67. Isolated mucinous adrenal metastasis in a breast cancer patient

Demirci U., BÜYÜKBERBER S., Cakir T., POYRAZ A., Baykara M., Karakus E., et al.

Journal of Oncology Pharmacy Practice , cilt.17, sa.4, ss.444-447, 2011 (Scopus)

68. Assessment of right ventricular functions during cancer chemotherapy.

Tanindi A., Demirci U., TAÇOY G., Buyukberber S., Alsancak Y., Coskun U., et al.

European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology , cilt.12, sa.11, ss.834-40, 2011 (SCI-Expanded, Scopus)

69. Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus

ÇETİN B. E., COŞKUN U., YILDIZ R., BÜYÜKBERBER S., Baykara M., BENEKLİ M.

Journal of Oncology Pharmacy Practice , cilt.17, sa.3, ss.274-278, 2011 (Scopus)

70. Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient

Demirci U., COŞKUN U., ERDEM Ö., Ozturk B., YILMAZ İ., BENEKLİ M., et al.

Journal of Oncology Pharmacy Practice , cilt.17, sa.3, ss.285-287, 2011 (Scopus)

71. Sister Mary Joseph's nodule as a rare sign of lymphoma

Cetin B., Benekli M., Bulutay P., AKYÜREK N., Cura E., Coskun U., et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.94, sa.2, ss.209-212, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

72. Ischemic colitis after capecitabine plus cisplatin treatment in advanced gastric cancer

Cetin B., Buyukberber S., Senturk S., Guzel E., Coskun U., Benekli M.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS , cilt.31, sa.4, ss.503-506, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Metastasis of rectal cancer to soft tissue of the hand: An unusual case

Cetin B., Buyukberber S., Yuksel M., Coskun U., YILDIZ R., Benekli M.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.22, sa.2, ss.229-230, 2011 (SCI-Expanded)

74. Primary adult soft tissue sarcomas: analysis of 294 patients

Alkis N., Muallaoglu S., Kocer M., Arslan U. Y., Durnali A. G., Tokluoglu S., et al.

MEDICAL ONCOLOGY , cilt.28, sa.1, ss.391-396, 2011 (SCI-Expanded, Scopus)

75. Serum granulocyte colony-stimulating factor levels in gliomas

Yildiz R., Coskun U., Buyukberber S., Sancak B., Kaya A. O., Gulbahar Ö., et al.

JOURNAL OF BUON , cilt.16, sa.1, ss.138-141, 2011 (SCI-Expanded, Scopus)

76. Intracystic papillary carcinoma of the breast: one of the youngest patient in the literature

Baykara M., Coskun U., Demirci U., YILDIZ R., Benekli M., Cakir A., et al.

MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1427-1428, 2010 (SCI-Expanded)

77. Peritumoral Lymphatic Microvessel Density Associated with Tumor Progression and Poor Prognosis in Gastric Carcinoma

Coskun U., AKYÜREK N., DURSUN A., Yamac D.

JOURNAL OF SURGICAL RESEARCH , cilt.164, sa.1, ss.110-115, 2010 (SCI-Expanded, Scopus)

78. The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer

YILDIZ R., Benekli M., Buyukberber S., Kaya A. O., Ozturk B., Yaman E., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.136, sa.10, ss.1471-1476, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide

Yaman E., Buyukberber S., Benekli M., Oner Y., Coskun U., AKMANSU M., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , cilt.112, sa.8, ss.662-667, 2010 (SCI-Expanded, Scopus)

80. Parathyroid Adenoma and Chondrosarcoma After Treatment of Pediatric Hodgkin Disease

Keskin E. Y., Gursel T., Uluoglu O., Albayrak M., KAYA Z., Coskun U., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.32, sa.7, 2010 (SCI-Expanded, Scopus)

81. Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens

Yildiz R., Kalender M. E., Dane F., Sevinc A., Gumus M., Camci C., et al.

Journal of Oncology Pharmacy Practice , cilt.16, sa.3, ss.173-178, 2010 (Scopus)

82. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

Tonyali O., Coskun U., YILDIZ R., KARAKAN T., Demirci U., AKYÜREK N., et al.

MEDICAL ONCOLOGY , cilt.27, sa.3, ss.768-773, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

83. Serum M30 levels are associated with survival in advanced gastric carcinoma patients

Yaman E., Coskun U., Sancak B., Buyukberber S., Ozturk B., Benekli M.

INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.10, sa.7, ss.719-722, 2010 (SCI-Expanded, Scopus)

84. Bilateral breast cancer in a survivor of acute lymphoblastic leukemia: a case report

Demirci U., Bugdayci F., Cakir A., Gurlek B., IŞIK GÖNÜL İ., Buyukberber S., et al.

MEDICAL ONCOLOGY , cilt.27, sa.2, ss.481-483, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

85. Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer

Kaya A. O., Buyukberber S., Dane F., Isikdogan A., Ustaalioglu B. O., Coskun U., et al.

TUMORI J , cilt.96, sa.3, ss.400-404, 2010 (SCI-Expanded)

86. Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer

Kaya A. O., Coskun U., Buyukberber S., Benekli M., Tekin E., Cifter C., et al.

JOURNAL OF BUON , cilt.15, sa.2, ss.248-254, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Four different malignancies in one patient: a case report.

Demirci U., Coşkun U., Göçün P. U., Gurlek B., Saka B., Oztürk B., et al.

Cases journal , cilt.3, ss.53, 2010 (Hakemli Dergi)

88. Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report

Demirci U., Buyukberber S., Yilmaz G., Ozturk B., AKYÜREK N., YILDIZ R., et al.

MEDICAL ONCOLOGY , cilt.27, sa.1, ss.62-64, 2010 (SCI-Expanded, Scopus)

89. Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer

Kaya A. O., Buyukberber S., Benekli M., Coskun U., Sevinc A., AKMANSU M., et al.

MEDICAL ONCOLOGY , cilt.27, sa.1, ss.152-157, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

90. Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) as potential tumor markers in non small cell lung cancer diagnosis.

Bahar B., Acedil Ayc Iota B., Çoşkun U., Büyükberber S., Benekli M., Yildiz R.

Asian Pacific journal of cancer prevention : APJCP , cilt.11, sa.3, ss.709-12, 2010 (SCI-Expanded, Scopus)

91. Bevacizumab Plus Irinotecan-Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens

YILDIZ R., Buyukberber S., ÜNER A., Yamac D., Coskun U., Kaya A. O., et al.

CANCER INVESTIGATION , cilt.28, sa.1, ss.33-37, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

92. Synchronous testicular liposarcoma and prostate adenocarcinoma: A case report

Demirci U., BÜYÜKBERBER S., ÇAKIR A., Ozturk B., AKYÜREK N., Unver B., et al.

Cases Journal , cilt.3, sa.1, 2010 (Scopus)

93. Synchronous Bilateral Breast Cancer in an Aged Male Patient

Yaman E., Ozturk B., Coskun U., Buyukberber S., Kaya A. O., YILDIZ R., et al.

ONKOLOGIE , cilt.33, sa.5, ss.255-258, 2010 (SCI-Expanded)

94. Adult hepatic epitheloid haemangioendothelioma presenting with Kasabach-Merrit syndrome: a case report

Ozturk B., Coskun U., Yaman E., Cakir A., Akdemir Ü. Ö., Yildiz R., et al.

JOURNAL OF CLINICAL PATHOLOGY , cilt.62, sa.11, ss.1053-1055, 2009 (SCI-Expanded, Scopus)

95. Primary pure small cell carcinoma of the urinary bladder that responded to carboplatin plus etoposide: a case report and review of the literature

Kaya A. O., Coskun U., Yildiz R., Gonul I. I., Karagulle K., Yaman E., et al.

JOURNAL OF BUON , cilt.14, sa.4, ss.703-706, 2009 (SCI-Expanded, Scopus)

96. Gemcitabine Combined With Uracil-Tegafur in Patients With Advanced Pancreatic Cancer

Coskun U., Alkis N., Celenkoglu G., Buyukberber S., ÖZKAN M., Camci C., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.101, sa.8, ss.761-764, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

97. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells

Donkor M. K., Lahue E., Hoke T. A., Shafer L. R., Coskun U., Solheim J. C., et al.

International Immunopharmacology , cilt.9, sa.7-8, ss.937-948, 2009 (SCI-Expanded, Scopus)

98. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors

Ozturk B., Coskun U., Sancak B., Yaman E., Buyukberber S., Benekli M.

INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.9, sa.5, ss.645-648, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

99. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma

Yaman E., Coskun U., Ozturk B., Buyukberber S., Kaya A. O., Coskun Ö., et al.

JOURNAL OF CLINICAL NEUROSCIENCE , cilt.16, sa.4, ss.591-592, 2009 (SCI-Expanded)

100. Vinorelbine in Combination with Carboplatin followed by Single-agent Consolidation Therapy for Unresectable Localized or Metastatic Non-small-cell Lung Carcinomas

Alici S., Coskun U., Alkis N., Sevinc A., Dane F., Gumus M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.10, sa.6, ss.1051-1055, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

101. Non-Gestational Uterine Choriocarcinoma in a Postmenopausal Woman

YILDIZ R., Benekli M., AKYÜREK N., Coskun U., Kaya A. O., Ozturk B., et al.

ONKOLOGIE , cilt.32, sa.7, ss.417-419, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

102. Metastatic fibroblastic reticulum cell sarcoma of the liver: pathological and PET-CT evaluation

Yaman E., IŞIK GÖNÜL İ., Buyukberber S., Ozturk B., AKYÜREK N., Coskun U., et al.

PATHOLOGY , cilt.41, sa.3, ss.289-292, 2009 (SCI-Expanded, Scopus)

103. UFT plus Oral Folinic Acid with Alternating Oral and Intravenous Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes

Coskun U., Kaya A. O., Alkis N., Buyukberber S., Alici S., Celenkoglu G., et al.

ONKOLOGIE , cilt.32, sa.10, ss.562-566, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

104. Gemcitabine-Induced Acute Coronary Syndrome: A Case Report

Ozturk B., TAÇOY G., Coskun U., Yaman E., Sahin G., Buyukberber S., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.18, sa.1, ss.76-80, 2009 (SCI-Expanded, Scopus)

105. Increased Serum Granulocyte Colony Stimulating Factor in Turkish Hepatocellular Carcinoma Patients

Kaya A. O., Coskun U., Sancak B., Buyukberber S., YILDIZ R., GÜLBAHAR Ö., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.10, sa.3, ss.403-405, 2009 (SCI-Expanded, Scopus)

106. Serum Granulocyte Macrophage-Colony Stimulating Factor: a Tumor Marker in Colorectal Carcinoma?

Demirci U., Coskun U., Sancak B., Ozturk B., Bahar B., Benekli M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.10, sa.6, ss.1021-1024, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

107. Serum neopterin levels in patients with breast cancer

Yildirim Y., GÜNEL N., Coskun U., PAŞAOĞLU H., Aslan S., Cetin A.

MEDICAL ONCOLOGY , cilt.25, sa.4, ss.403-407, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. Histiocytic sarcoma: PET-CT evaluation of a rare entity

Yaman E., Ozturk B., ERDEM O. A., Gokcora N., Coskun U., Uluoglu O., et al.

ANNALS OF NUCLEAR MEDICINE , cilt.22, sa.8, ss.715-717, 2008 (SCI-Expanded, Scopus)

109. The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma

Ozturk B., Buyukberber S., Akmansu M., Coskun U., Yamac D., Uner A., et al.

MEDICAL ONCOLOGY , cilt.25, sa.3, ss.269-273, 2008 (SCI-Expanded, Scopus)

110. Intrasellar plasmacytoma: an unusual presentation of multiple myeloma

Yaman E., Benekli M., Coskun U., Sezer K., Ozturk B., Kaya A. O., et al.

ACTA NEUROCHIRURGICA , cilt.150, sa.9, ss.921-924, 2008 (SCI-Expanded, Scopus)

111. Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer

Acar A., Onan A., Coskun U., ÜNER A., BAĞRIAÇIK E. Ü., Atalay F., et al.

MEDICAL ONCOLOGY , sa.3, ss.279-283, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

112. Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas

Yaman E., Buyukberber S., ÜNER A., Coskun U., Yamac D., Ozturk B., et al.

TUMORI J , cilt.94, sa.5, ss.674-680, 2008 (SCI-Expanded, Scopus)

113. WITHDRAWN: Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients.

Coşkun U., Günel N., Sancak B., Günel U., Onuk E., Bayram O., et al.

Breast (Edinburgh, Scotland) , 2008 (SCI-Expanded, Scopus)

114. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer

Yamac D., Ozturk B., Coskun U., Tekin E., Sancak B., YILDIZ R., et al.

ADVANCES IN THERAPY , cilt.25, sa.8, ss.801-809, 2008 (SCI-Expanded)

115. Serum big endothelin-1 levels in female patients with breast cancer

Yildirim Y., GÜNEL N., Coskun U., Sancak B., BUKAN N., Aslan S., et al.

INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.8, sa.8, ss.1119-1123, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

116. Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane plus platinum regimens

Coskun U., Kaya A. O., Buyukberber S., Benekli M., ÜNER A., Dikilitas M., et al.

MEDICAL ONCOLOGY , cilt.25, sa.2, ss.133-136, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

117. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules - Utility of 18F-FDG PET in staging

Berk V., YILDIZ R., AKDEMİR Ü. Ö., AKYÜREK N., KARABACAK N., Coskun U., et al.

CLINICAL NUCLEAR MEDICINE , cilt.33, sa.5, ss.365-366, 2008 (SCI-Expanded, Scopus)

118. Reply to the article "Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases" by J.-J. Body et al. (Ann Oncol 2007; 18 : 1165-1171)

Yaman E., Benekli M., Coskun U., Ozturk B., Kaya A. O., Yildiz R., et al.

ANNALS OF ONCOLOGY , cilt.19, sa.2, ss.397-398, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. Coexistence of Gastrointestinal Stromal Tumor (GIST) of the Rectum and Adenocarcinoma of the Prostate in a Patient with Familial GIST

Yaman E., Coskun U., Benekli M., Sozen S., Yamac D., Buyukberber S., et al.

ONKOLOGIE , cilt.31, sa.12, ss.697-699, 2008 (SCI-Expanded, Scopus)

120. Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer

Kaya A. O., Buyukberber S., Coskun U., YILDIZ R., Ozturk B., Yaman E., et al.

CUTANEOUS AND OCULAR TOXICOLOGY , cilt.27, sa.4, ss.327-331, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

121. Synchronize primary breast osteosarcoma and contralateral benign cystosarcoma phylloides: Radiologic and pathologic imaging

ÜNER A., Ozturk B., Benekli M., Coskun U., Kocak S., Kaya A. O., et al.

BREAST JOURNAL , cilt.14, sa.1, ss.109-110, 2008 (SCI-Expanded, Scopus)

122. Temozolomide in newly diagnosed malignant gliomas: Administered concomitantly with radiotherapy, and thereafter as consolidation treatment

Yaman E., Buyukberber S., ÜNER A., Coskun U., AKMANSU M., Benekli M., et al.

ONKOLOGIE , cilt.31, sa.6, ss.309-313, 2008 (SCI-Expanded, Scopus)

123. Whole Body 18F-FDG PET/CT Imaging in the Detection of Primary Tumours in Patients with a Metastatic Carcinoma of Unknown Origin

Kaya A. O., Coskun U., ÜNLÜ M., AKDEMİR Ü. Ö., ÖZDEMİR N., Zengin N., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.9, sa.4, ss.683-686, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

124. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients

Coskun U., Buyukberber S., Yaman E., Uner A., Er O., Ozkan M., et al.

NEOPLASMA , cilt.55, sa.1, ss.65-70, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

125. Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma

Yamac D., Ayyildiz T., Coskun U., AKYÜREK N., DURSUN A., Seckin S., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.204, sa.8, ss.527-536, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

126. Serum and ascitic fluid superoxide dismutase and malondialdehyde levels in patients with cirrhosis

Ozenirler S., Sancak B., COŞKUN U.

Biomarker Insights , cilt.2008, sa.3, ss.141-145, 2008 (Scopus)

127. F-18FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient

Yildiz R., Coskun U., Kapucu O., Kaya A. O., Akdemir Ü. Ö., Benekli M., et al.

CLINICAL NUCLEAR MEDICINE , cilt.32, sa.6, ss.471-473, 2007 (SCI-Expanded, Scopus)

128. Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer

Yildiz R., Coskum U., Kaya A. C., Ozturk B., Yaman E.

ANNALS OF PHARMACOTHERAPY , cilt.41, sa.5, ss.901-902, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

129. Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes

Benekli M., YILDIZ R., ÜNER A., Er O., Yamac D., Alkis N., et al.

ONCOLOGY , cilt.72, ss.308-313, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

130. Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?

Coskun U., Yamac D., Gulbahar Ö., Sancak B., Karaman N., Ozkan S.

NEOPLASMA , cilt.54, sa.4, ss.348-352, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

131. Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

Yaman E., Uner A., Er O., Coskun U., Buyukberber S., Dikilitas M., et al.

MEDICAL ONCOLOGY , cilt.24, sa.4, ss.431-435, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

132. Solitary iris metastasis from breast cancer with dramatic course: case report

Ozturk B., Buyukberber S., Coskun U., Yaman E., Yildiz R., Kaya A. O., et al.

MEDICAL ONCOLOGY , cilt.24, sa.4, ss.463-465, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

133. Serum P-selectin, soluble vascular cell adhesion molecule-I (s-VCAM-I) and soluble intercellular adhesion molecule-I (s-ICAM-I) levels in bladder carcinoma patients with different stages

Coskun U., Sancak B., Sen İ., Bukan N., Tufan M., Gulbahar Ö., et al.

INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.6, sa.4, ss.672-677, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

134. Interdigitating dendritic cell tumor with breast and cervical lymph-node involvement: a case report and review of the literature

Uluoglu O., Akyurek N., Uner A., Coskun U., Ozdemir A., Gokcora N.

VIRCHOWS ARCHIV , cilt.446, sa.5, ss.546-554, 2005 (SCI-Expanded, Scopus)

135. The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma

ERDEM O. A., Dursun A., Coskun U., Gunel N.

TUMORI J , cilt.91, sa.1, ss.46-52, 2005 (SCI-Expanded, Scopus)

136. Prognostic importance of COX-2 expression in patients with colorectal cancer

Yamac D., Celenkoglu G., Coskun U., Akyurek N., Akcali Z., Dursun A., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.201, sa.7, ss.497-502, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

137. Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients

Coskun U., Gunel N., Sancak B., Onuk E., Bayram M., Cihan A.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.137, sa.3, ss.546-551, 2004 (SCI-Expanded, Scopus)

138. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.

Sancak B., Coskun U., Gunel N., Onuk E., Cihan A., Karamercan A., et al.

Internal medicine journal , cilt.34, sa.6, ss.310-5, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

139. Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade.

Sözen S., Coskun U., Sancak B., Bukan N., Günel N., Tunc L., et al.

Neoplasma , cilt.51, sa.1, ss.25-9, 2004 (SCI-Expanded, Scopus)

140. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions

Coskun U., Bukan N., Sancak B., Gunel N., Ozenirler S., Unal A., et al.

NEOPLASMA , cilt.51, sa.3, ss.209-213, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

141. Polymyositis and hepatitis concurrent with breast cancer

Yamac D., Gunel N., Goker B., Coskun U., ERDEM O. A., Akyol G., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.13, sa.3, ss.171-175, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

142. Prognostic value of serum IL-18 and nitric oxide activity in breast cancer patients at operable stage

Gunel N., Coskun U., Sancak B., Hasdemir O., Sare M., Bayram O., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.26, sa.4, ss.416-421, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

143. Serum interleukin-18 and nitric oxide activity in bladder carcinoma

Bukan N., Sozen S., Coskun U., Sancak B., Gunel N., Bozkirli I., et al.

EUROPEAN CYTOKINE NETWORK , cilt.14, sa.3, ss.163-167, 2003 (SCI-Expanded, Scopus)

144. Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patients

Coskun U., Gunel N., Sancak B., Gunel U., Onuk E., Bayram O., et al.

BREAST , cilt.12, sa.2, ss.104-110, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

145. Gingival metastasis of malignant mesenchymal tumour in the thigh

Gunel N., Coskun U., Simsek B., Seckin S., Cengiz O., Gunel U., et al.

BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY , cilt.41, sa.1, ss.59-61, 2003 (SCI-Expanded, Scopus)

146. Serum leptin levels are associated with tamoxifen-induced hepatic steatosis.

Gunel N., Coskun U., Toruner F. S., Sancak B., Yilmaz E., Cengiz O., et al.

Current medical research and opinion , cilt.19, sa.1, ss.47-50, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. Invaziv Timoma ve Myastenia Gravis Bir Vaka Sunumu

Yıldırım Y., COŞKUN Ö., COŞKUN U., KUTLU G., UYSAL H., Üçler S., et al.

Türk Nöroloji Dergisi , cilt.9, sa.1, ss.113-117, 2003 (Hakemli Dergi)

148. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.

Coskun U., Gunel N., Onuk E., Yilmaz E., Bayram O., Yamac D., et al.

Neoplasma , cilt.50, sa.3, ss.210-6, 2003 (SCI-Expanded, Scopus)

149. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.

Coskun U., Gunel N., Toruner F. S., Sancak B., Onuk E., Bayram O., et al.

Neoplasma , cilt.50, sa.1, ss.41-6, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

150. Primary mediastinal yolk sac tumor in a 66-year-old woman

Coskun U., Gunel N., Yildirim Y., Memis L., Boyacioglu Z.

MEDICAL PRINCIPLES AND PRACTICE , cilt.11, sa.4, ss.218-220, 2002 (SCI-Expanded, Scopus)

151. Primary high grade malignant lymphoma of bladder

Coskun U., Gunel N., EROĞLU A., Biri H., Poyraz A., Gurocak S., et al.

UROLOGIC ONCOLOGY , cilt.7, sa.5, ss.181-183, 2002 (SCI-Expanded, Scopus)

152. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients

Gunel N., Coskun U., Sancak B., Gunel U., Hasdemir O., Bozkurt S.

CANCER , cilt.95, sa.3, ss.663-667, 2002 (SCI-Expanded, Scopus)

153. A case of Sweet's syndrome developed after the treatment of herpes simplex infection in a metastatic breast cancer patient

Coskun U., Gunel N., Senol E., Ilter N., Dursun A., Tuzun D.

JOURNAL OF CUTANEOUS PATHOLOGY , cilt.29, sa.5, ss.301-304, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Yayınlar & Eserler